Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
Total Valuation
Conmed has a market cap or net worth of $1.41B. The enterprise value is $2.47B.
Market Cap$1.41B
Enterprise Value$2.47B
Share Statistics
Conmed has 30,954,964 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,954,964
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Conmed’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 7.99%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.99%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee335.13K
Profits Per Employee33.95K
Employee Count3,900
Asset Turnover0.57
Inventory Turnover1.66
Valuation Ratios
The current PE Ratio of Conmed is 12.9. Conmed’s PEG ratio is 0.15.
PE Ratio12.9
PS Ratio1.62
PB Ratio2.19
Price to Fair Value2.19
Price to FCF13.72
Price to Operating Cash Flow7.80
PEG Ratio0.15
Income Statement
In the last 12 months, Conmed had revenue of 1.31B and earned 132.42M in profits. Earnings per share was 4.29.
Revenue1.31B
Gross Profit733.03M
Operating Income200.33M
Pretax Income163.03M
Net Income132.42M
EBITDA272.18M
Earnings Per Share (EPS)4.29
Cash Flow
In the last 12 months, operating cash flow was 167.69M and capital expenditures -18.73M, giving a free cash flow of 148.96M billion.
Operating Cash Flow167.69M
Free Cash Flow148.96M
Free Cash Flow per Share4.81
Dividends & Yields
Conmed pays an annual dividend of $0.2, resulting in a dividend yield of 2%
Dividend Per Share$0.2
Dividend Yield2%
Payout Ratio17.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-45.61%
50-Day Moving Average44.80
200-Day Moving Average51.97
Relative Strength Index (RSI)33.92
Average Volume (3m)368.83K
Important Dates
Conmed upcoming earnings date is Jan 29, 2026, After Close (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateJan 29, 2026
Ex-Dividend DateSep 15, 2025
Financial Position
Conmed as a current ratio of 2.30, with Debt / Equity ratio of 87.93%
Current Ratio2.30
Quick Ratio1.05
Debt to Market Cap0.43
Net Debt to EBITDA3.67
Interest Coverage Ratio5.37
Taxes
In the past 12 months, Conmed has paid 30.61M in taxes.
Income Tax30.61M
Effective Tax Rate0.19
Enterprise Valuation
Conmed EV to EBITDA ratio is 12.06, with an EV/FCF ratio of 19.71.
EV to Sales2.32
EV to EBITDA12.06
EV to Free Cash Flow19.71
EV to Operating Cash Flow18.17
Balance Sheet
Conmed has $38.93M in cash and marketable securities with $853.75M in debt, giving a net cash position of -$814.82M billion.
Cash & Marketable Securities$38.93M
Total Debt$853.75M
Net Cash-$814.82M
Net Cash Per Share-$26.32
Tangible Book Value Per Share-$14.92
Margins
Gross margin is 56.12%, with operating margin of 15.33%, and net profit margin of 10.13%.
Gross Margin56.12%
Operating Margin15.33%
Pretax Margin12.47%
Net Profit Margin10.13%
EBITDA Margin19.25%
EBIT Margin15.33%
Analyst Forecast
The average price target for Conmed is $53.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$53.50
Price Target Upside20.63% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast4.69%
EPS Growth Forecast-51.57%